These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 357051)
1. Effect of niridazole in cellular immunity in vivo and in vitro. Solbach W; Wagner H; Röllinghoff M Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051 [TBL] [Abstract][Full Text] [Related]
2. Marked suppression of cell-mediated immunity with niridazole: first report. Mahmoud AA; Warren KS; Mandel MA Surg Forum; 1974; 25(0):514-6. PubMed ID: 4612800 [No Abstract] [Full Text] [Related]
3. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Perez MI; Edelson RL; John L; Laroche L; Berger CL Yale J Biol Med; 1989; 62(6):595-609. PubMed ID: 2636801 [TBL] [Abstract][Full Text] [Related]
4. Marked prolongation of skin homograft survival with niridazole. A first report. Mandel MA; Mahmoud AA; Warren KS Plast Reconstr Surg; 1975 Jan; 55(1):76-89. PubMed ID: 1089984 [TBL] [Abstract][Full Text] [Related]
5. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens. Williams IR; Perry LL J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the mechanism of allograft rejection and cell-mediated immunity. II. Divergent effect of CY pretreatment on the generation of cytotoxic activity in the draining lymph nodes and spleen. Nanishi F; Taniguchi K; Kubo C; Onoyama K; Omae T; Nomoto K J Clin Lab Immunol; 1983 Sep; 12(1):23-30. PubMed ID: 6631941 [TBL] [Abstract][Full Text] [Related]
7. Niridazole, a potent long-acting suppressant of cellular hypersensitivity. III. Minimal suppression of antibody responses. Pelley RP; Pelley RJ; Stavitsky AB; Mahmoud AA; Warren KS J Immunol; 1975 Dec; 115(6):1477-82. PubMed ID: 1184961 [TBL] [Abstract][Full Text] [Related]
8. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Bishop DK; Shelby J; Eichwald EJ Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses. Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140 [TBL] [Abstract][Full Text] [Related]
10. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection. Orosz CG; Sirinek LP; Zinn NE; Ferguson RM Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303 [No Abstract] [Full Text] [Related]
11. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. Perez M; Edelson R; Laroche L; Berger C J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941 [TBL] [Abstract][Full Text] [Related]
12. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes. Tyler JD; Steinmuller D J Immunol; 1981 May; 126(5):1759-63. PubMed ID: 7012238 [TBL] [Abstract][Full Text] [Related]
13. T cell subsets in the immune rejection of murine heterotopic corneal allografts. Matoba AY; Peeler JS; Niederkorn JY Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells. Nanishi F; Nomoto K; Taniguchi K; Kubo C Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243 [TBL] [Abstract][Full Text] [Related]
15. Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo. Sakemi T; Kuroiwa A; Nomoto K Immunology; 1980 Oct; 41(2):297-302. PubMed ID: 6969217 [TBL] [Abstract][Full Text] [Related]
16. The 1995 Moyer Award. The effect of burn injury on allograft rejection, alloantigen processing, and cytotoxic T-lymphocyte sensitization. Hultman CS; Cairns BA; Yamamoto H; deSerres S; Frelinger JA; Meyer AA J Burn Care Rehabil; 1995; 16(6):573-80. PubMed ID: 8582933 [TBL] [Abstract][Full Text] [Related]
17. In vivo function tests of the effect of tilorone and niridazole on cell-mediated immunity in chickens. Donahoe JP; Giambrone J; Fletcher OJ; Kleven SH Am J Vet Res; 1977 Dec; 38(12):2013-7. PubMed ID: 23063 [TBL] [Abstract][Full Text] [Related]
18. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [TBL] [Abstract][Full Text] [Related]
19. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice. Krulová M; Zajícová A; Fric J; Holán V Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167 [TBL] [Abstract][Full Text] [Related]
20. Augmentation of cell-mediated cytotoxicity by short-term in vitro precultivation of effector cells. Steinmuller D; Santee LJ; Krco CJ Transplant Proc; 1979 Mar; 11(1):834-6. PubMed ID: 377716 [No Abstract] [Full Text] [Related] [Next] [New Search]